Pfizer Inc. (PFE) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-02 (expected, before the open). EPS estimate 0.69, revenue estimate 17.22B.
Over the last 12 reports the stock moved 2.1% on average (either way), rising 8 times and falling 4. EPS beat estimates 12 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-03 | 0.87 | 0.74 | +18.4% | 16.58B | 15.85B | +0.4% |
| Q2 FY2026 | 2026-08-04 | 0.77 | 0.68 | +12.9% | 15.03B | 14.40B | +3.1% |
| Q1 FY2026 | 2026-05-05 | 0.75 | 0.72 | +3.9% | 14.45B | 13.84B | +0.9% |
| Q4 FY2025 | 2026-02-03 | 0.66 | 0.57 | +16.4% | 17.56B | 16.85B | +0.5% |
| Q3 FY2025 | 2025-11-04 | 0.87 | 0.63 | +37.4% | 16.65B | 16.50B | -0.2% |
| Q2 FY2025 | 2025-08-05 | 0.78 | 0.58 | +34.5% | 14.65B | 13.56B | +1.7% |
| Q1 FY2025 | 2025-04-29 | 0.92 | 0.67 | +38.1% | 13.72B | 13.92B | +5.9% |
| Q4 FY2024 | 2025-02-04 | 0.63 | 0.47 | +33.6% | 17.76B | 17.35B | +0.9% |